References
- Ayala G, Wang D, Wulf G, et al (2003). The prolyl isomerase Pin1 is a novel prognostic marker in human prostate cancer. Cancer Res, 63, 6244-51.
- Begg CB, Mazumdar M (1994). Operating characteristics of a rank correlation test for publication bias. Biometrics, 50, 1088-101. https://doi.org/10.2307/2533446
- Cao WP, Tang HL, Lin P (2012). Association between polymorphisms in prolyl isomerase Pin1 and risk for laryngeal squamous cell carcinoma. Jiangsu Med, 38, 1067-670.
- Carpenter RW, Tomko RL, Trull TJ, Boomsma DI. (2013). Gene-environment studies and borderline personality disorder: a review. Curr Psychiatry Rep, 15, 336. https://doi.org/10.1007/s11920-012-0336-1
- Chung CC, Chanock SJ (2011). Current status of genome-wide association studies in cancer. Hum Genet, 130, 59-78. https://doi.org/10.1007/s00439-011-1030-9
- DeYoung CG, Clark R (2012). The gene in its natural habitat: the importance of gene-trait interactions. Dev Psychopathol, 24, 1307-18. https://doi.org/10.1017/S0954579412000727
- Dick, DM (2011). Gene-environment interaction in psychological traits and disorders. Annu Rev Clin Psychol, 7, 383-409. https://doi.org/10.1146/annurev-clinpsy-032210-104518
- Egger M, Davey Smith G, Schneider M, Minder C (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ, 315, 629-34. https://doi.org/10.1136/bmj.315.7109.629
- Euhus DM, Robinson L (2013). Genetic predisposition syndromes and their management. Surg Clin North Am, 93, 341-62. https://doi.org/10.1016/j.suc.2013.01.005
- Fukuchi M, Fukai Y, Kimura H, et al (2006). Prolyl isomerase Pin1 expression predicts prognosis in patients with esophageal squamous cell carcinoma and correlates with cyclinD1 expression. Int J Oncol, 29, 329-34.
- Gao LB, Pan XM, Sun H, et al (2010). The association between ATM D1853N polymorphism and breast cancer susceptibility: a meta-analysis. J Exp Clin Cancer Res, 29, 117. https://doi.org/10.1186/1756-9966-29-117
- Han CH, Lu J, Wei Q, et al (2010). The functional promoter polymorphism (-842G>C) in the PIN1 gene is associated with decreased risk of breast cancer in non-Hispanic white women 55 years and younger. Breast Cancer Res Treat, 122, 243-9. https://doi.org/10.1007/s10549-009-0682-9
- He J, Zhou F, Shao K, et al (2007). Overexpression of Pin1 in non-small cell lung cancer (NSCLC) and its correlation with lymph node metastases. Lung Cancer, 56, 51-8. https://doi.org/10.1016/j.lungcan.2006.11.024
- Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003). Measuring inconsistency in meta-analyses. BMJ, 327, 557-60. https://doi.org/10.1136/bmj.327.7414.557
- Liou YC, Zhou XZ, Lu KP (2011). Prolyl isomerase Pin1 as a molecular switch to determine the fate of phosphoproteins. Trends Biochem Sci, 36, 501-14. https://doi.org/10.1016/j.tibs.2011.07.001
- Lu J, Hu Z, Wei S, et al (2009). A novel functional variant (-842G>C) in the PIN1 promoter contributes to decreased risk of squamous cell carcinoma of the head and neck by diminishing the promoter activity. Carcinogenesis, 30, 1717-21. https://doi.org/10.1093/carcin/bgp171
- Lu J, Yang L, Zhao H, et al (2011). The polymorphism and haplotypes of PIN1 gene are associated with the risk of lung cancer in Southern and Eastern Chinese populations. Hum Mutat, 32, 1299-308. https://doi.org/10.1002/humu.21574
- Lu KP, Zhou XZ (2007). The prolyl isomerase PIN1: a pivotal new twist in phosphorylation signalling and disease. Nat Rev Mol Cell Biol, 8, 904-16. https://doi.org/10.1038/nrm2261
- Lu Y, Huang GL, Pu XX, et al (2013). Association between PIN1 promoter polymorphisms and risk of nasopharyngeal carcinoma. Mol Biol Rep, 40, 3777-82. https://doi.org/10.1007/s11033-012-2454-6
- Miyashita H, Mori S, Motegi K, et al (2003). Pin1 is overexpressed in oral squamous cell carcinoma and its levels correlate with cyclin D1 overexpression. Oncol Rep, 10, 455-61.
- Molina JD, Lopez-Munoz F, Stein DJ, et al (2009). Borderline personality disorder: a review and reformulation from evolutionary theory. Med Hypotheses, 73, 382-6. https://doi.org/10.1016/j.mehy.2009.03.024
- Naidu R, Har YC, Taib NA (2011). Analysis of peptidyl-propyl-cis/trans isomerase 1 (PIN1) gene -842(G > C) and -667(T> C) polymorphic variants in relation to breast cancer risk and clinico-pathological parameters. Scand J Clin Lab Invest, 71, 500-6. https://doi.org/10.3109/00365513.2011.590223
- Perez-Losada J, Castellanos-Martin A, Mao JH (2011). Cancer evolution and individual susceptibility. Integr Biol (Camb), 3, 316-28. https://doi.org/10.1039/c0ib00094a
- Ramsberg J, Asseburg C, Henriksson M (2012). Effectiveness and cost-effectiveness of antidepressants in primary care: a multiple treatment comparison meta-analysis and cost-effectiveness model. PLoS One, 7, e42003. https://doi.org/10.1371/journal.pone.0042003
- Segat L, Milanese M, Crovella S (2007). Pin1 promoter polymorphisms in hepatocellular carcinoma patients. Gastroenterology, 132, 2618-9; author reply 9-20. https://doi.org/10.1053/j.gastro.2007.04.037
- Theuerkorn M, Fischer G, Schiene-Fischer C (2011). Prolyl cis/trans isomerase signalling pathways in cancer. Curr Opin Pharmacol, 11, 281-7. https://doi.org/10.1016/j.coph.2011.03.007
- Xue H, Lin B, Ni P, et al (2010). Interleukin-1B and interleukin-1 RN polymorphisms and gastric carcinoma risk: a meta-analysis. J Gastroenterol Hepatol, 25, 1604-17. https://doi.org/10.1111/j.1440-1746.2010.06428.x
- You Y, Deng J, Zheng J, et al (2013). Functional polymorphisms in PIN1 promoter and esophageal carcinoma susceptibility in Chinese population. Mol Biol Rep, 40, 829-38. https://doi.org/10.1007/s11033-012-2122-x
- Zhao H (2009). Association between polymorphisms in prolyl isomerase Pin1 promoter and risk for lung cancer. . Guangzhou Medical University: [D] Guangzhou.
Cited by
- Four Polymorphisms in the Cytochrome P450 1A2 (CYP1A2) Gene and Lung Cancer Risk: a Meta-analysis vol.15, pp.14, 2014, https://doi.org/10.7314/APJCP.2014.15.14.5673